931
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Telehealth for opioid use disorder: retention as a function of demographics and rurality

ORCID Icon, ORCID Icon, , , & ORCID Icon
Pages 260-265 | Received 10 Aug 2022, Accepted 08 Feb 2023, Published online: 24 Mar 2023

References

  • Kaiser Family Foundation. Telehealth Has Played an Outsized Role Meeting Mental Health Needs During the COVID-19 Pandemic. 2022. [Accessed 2022 Mar 6] https://www.kff.org/coronavirus-covid-19/issue-brief/telehealth-has-played-an-outsized-role-meeting-mental-health-needs-during-the-covid-19-pandemic/
  • Mark TL, Treiman K, Padwa H, Henretty K, Tzeng J, Gilbert M. Addiction treatment and telehealth: review of efficacy and provider insights during the COVID-19 pandemic. Psych Services. 2021;73:1–8. doi:10.1176/appi.ps.202100088.
  • Joudrey PJ, Kolak M, Lin Q, Paykin S, Anguiano V, Wang EA. Assessment of community-level vulnerability and access to medications for opioid use disorder. JAMA Netw Open. 2022;5:e227028. doi:10.1001/jamanetworkopen.2022.7028.
  • Weintraub E, Seneviratne C, Anane J, Coble K, Magidson J, Kattakuzhy S, Greenblatt A, Welsh C, Pappas A, Ross TL, et al. Mobile telemedicine for buprenorphine treatment in rural populations with opioid use disorder. JAMA Netw Open. 2021;4:e2118487. doi:10.1001/jamanetworkopen.2021.18487.
  • Alegría M, Frank RG, Hansen HB, Sharfstein JM, Shim RM, Tierney M. Transforming mental health and addiction services. Health Aff. 2021;40:226–34. doi:10.1377/hlthaff.2020.01472.
  • McNeely J, Schatz D, Olfson M, Williams AR, Williams AR. How physician workforce shortages are hampering the response to the opioid crisis. Psychiatric Services. 2021 Sep 15;73:202000565. appips Epub ahead of print. PMID: 34521210 doi:10.1176/appi.ps.202000565.
  • Verma S. Early impact of CMS expansion of medicare telehealth during COVID-19. Health Aff. 2020 July 15. doi:10.1377/forefront.20200715.454789.
  • Samples H, Williams AR, Olfson M, Crystal S. Risk factors for premature discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees. J Subst Abus Treat. 2018 Dec;95:9–17. PMC6354252 doi:10.1016/j.jsat.2018.09.001.
  • Williams AR, Samples H, Crystal S, Olfson M. Retention on buprenorphine beyond six months and risk of acute care service utilization, opioid prescription use, and overdose. Am J Psych. 2019 Feb 1;177:117–24. doi:10.1176/appi.ajp.2019.19060612.
  • Santo JT, Clark B, Hickman M, Grebely J, Campbell G, Sordo L, Chen A, Tran LT, Bharat C, Padmanathan P, et al. Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis. JAMA Psychiatry. 2021 Jun 2;78:979. doi:10.1001/jamapsychiatry.2021.0976.
  • Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, Ferri M, Pastor-Barriuso R. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:1–14. doi:10.1136/bmj.j1550.
  • National Quality Forum. Behavioral health 2016-2017 final report. 2017. [Accessed 2022 Mar 6]. https://www.qualityforum.org/Publications/2017/08/Behavioral_Health_2016-2017_Final_Report.aspx
  • Williams AR, Mauro CM, Feng T, Wilson A, Cruz A, Olfson M, Crystal S, Samples H, Chiodo L. Performance measurement for opioid use disorder medication treatment and care retention. AJP. Published online 2022 Oct 26;20220456. appi.ajp. doi:10.1176/appi.ajp.20220456.
  • U.S. Census Bureau. 2016-2020 American community survey 5-year estimates. [accessed 2022 October 24]. https://www.census.gov/data/developers/data-sets/acs-5year.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.